When to implement a commercial patient access programme

Dane TN
Posted: 08/29/2017

Dane Hartung, Director Marketing and Access, Fougera Pharmaceuticals shares best practices for determining if and when you should implement a new Commercial Patient Access Program. Dane also discusses how you should go about ensuring your patient access program is ethical, compliant and effectively differentiates your product.

Interested in learning more about this topic?
EE agenda
Download the agenda for: Pre-Approval Access Programs 2017

The Pre-approval Access Programs conference offers the chance to benchmark with key opinion leaders, connect with like-minded peers, and share different perspectives. This extensive program will highlight the most challenging regulatory requirements and best practices in creating a streamlined pre-approval access program.

 

Dane will be presenting at the Pre-Approval Access Programs this September 25-27th in Philadelphia, PA. 

Download the article via the button below

Dane TN
Posted: 08/29/2017

Pharma IQ Members

EVENTS OF INTEREST

London, UK
November 27 - 28, 2017
Vienna Marriott Hotel, Vienna, Austria
November 26 - 28, 2017
Hilton Brussels Grand Place, Brussels, Belgium
November 27 - 29, 2017